Faricimab, compared with aflibercept, reduces the risk of epiretinal membrane formation in eyes with diabetic macular edema, research shows.

Two inflammatory tear fluid biomarkers may serve a diagnostic purpose in thyroid eye disease, according to a cross-sectional study.